foxo4 dri cancer Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cells Development of a novel senolytic – FOXO4-DRI PEPTIDE 2MG/5MG/10MG VIAL –

foxo4 dri cancer

foxo4 dri cancer Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cells Development of a novel senolytic – FOXO4-DRI PEPTIDE 2MG/5MG/10MG VIAL –

Name: foxo4 dri cancer Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cells Development of a novel senolytic – FOXO4-DRI PEPTIDE 2MG/5MG/10MG VIAL –
Brand: wefit.es
SKU: 58401078182
Price: 21.92 USD
Availability: InStock
Rating: 4.6165 (10 reviews)

SKU: 58401078182

4.6

USD21.92 USD42.92

Pay in 4 interest-free payments of $5.48 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 16 - Aug 21

Description

Bifunctional PEGylated exenatide-amylinomimetic hybrids to treat metabolic disorders: an example of long-acting dual hormonal therapeutics

If inhibiting NAD+ synthesis has an adverse effect on 5-amino-1MQs muscle-enhancing effects, this would show that, indeed, the compound likely works through increasing NAD+ levels